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In order to analyse temporal trends in vertical transmission
rates of human immunodeficiency virus (HIV) and deter-
minant of congenital HIV infection in Italy, we have
considered data from a network of hospitals co-operating
in the Italian Collaborative Study on HIV infection in
pregnancy, conducted between 1988 and 1995. A total of
1040 women entered the study. The HIV-1 status of the
babies was known in 848 cases (81.5%). Transmission rates
were highest in the period 1988–1991, then tended to
decrease and in 1995 the rate was 9.7 per 100 children
(this finding, however, was based on only six infected
children and the trend was not statistically significant).
Considering the overall series, the risk of vertical HIV
transmission was higher in women with low CD4 count in
pregnancy [odds ratio (OR) ,400 versus ù400 1.8, 95%
confidence interval (CI) 1.1–2.9]. In comparison with
vaginal delivery the risk of transmission was 0.3 (95% CI
0.1–0.5) and 0.6 (95% CI 0.3–1.2) respectively for elective
and emergency delivery. In comparison with women who
delivered at term (ù37 gestation weeks) the OR of HIV
infection of the babies for the whole series was 2.2 (95%
CI 1.3–3.6) in women who delivered preterm. Similar
findings emerged when the analysis was conducted con-
sidering, separately, subjects observed in the period 1988–
1991 and 1992–1995. The frequency of Caesarean section
increased from 26.5% of deliveries in 1988–1991 to 36.2%
in 1992–1995. Consequently, most temporal differences
disappeared after standardization for mode of delivery,
but the rate in 1995 was still lower than in 1988–1994.
*Istituto di Ricerche Farmacologiche ‘Mario Negri’ Milano [E.Ricci,
F.Parazzini, E.Di Cintio, L.Chatenoud (data analysis)]; Bari,
Policlinico (L.Selvaggi, P.Greco, A.Vimercati); Bologna, Ospedale S.
Orsola (L.Bovicelli, B.Guerra, S.Bianchi); Brescia, Spedali Civili,
Div. O.G. (U.Bianchi); Brescia, Spedali Civili, Dip. Materno Infantile
(E. Prati, M.Lomini); Firenze, Policlinico Careggi (G.Massi,
T.A.Innocenti); Milano, Ospedale S. Paolo (A.E.Semprini, M.Ravizza,
C.Castagna, M.Della Torre, G.Pardi); Milano, Ospedale Sacco
(M.Conti, M.L.Muggiasca, E.Ghetti); Milano, Istituto Clinici
Perfezionamento (M.Vignali, A.Bucceri); Napoli, Istituto O.G.
(U.Montemango, P.Martinelli); Padova, Istituto O.G. (L.Di Lenardo,
A.Russolo); Pavia, Policlinico S. Matteo (C.Zara, A.Spinillo); Roma,
Policlinico Umberto I (A.Pachı`, G.Scaravelli); Roma, Universita`
Cattolica (S.Mancuso, M.De Santis, P.Villa); Torino, Universita`
(C.Benedetto, C.Tibaldi, N.Ziarati)
242 © European Society of Human Reproduction and Embryology
Key words: epidemiology/HIV infection/risk factors/vertical
transmission
Introduction
The rate of vertical transmission of human immunodeficiency
virus (HIV) in Europe is declining. Studies in the mid-1980s
reported a 25–30% incidence of congenital HIV infection, but
surveys in the early 1990s have found a 10–15% mother-to-
child transmission rate (European Collaborative Study, 1994,
1996; European Collaborative Study and the Swiss HIV
Pregnancy Cohort, 1997; Maguire et al., 1997; Byers et al.,
1998). This decline may depend on the changing characteristics
of the population of HIV-infected pregnant women, with an
increase in women with asymptomatic disease, or on changes
in obstetric management with interventions aimed at reducing
the vertical transmission of the virus. Some studies have
indicated that delivery by Caesarean section reduces the
incidence of congenital infection (Dunn et al., 1994; European
Collaborative Study, 1994) and a randomized trial found that
giving zidovudine to the mother reduced the risk of transmis-
sion by 70% (Connor et al., 1994). The encouraging results
of these studies may have led to an increased number of
women with HIV being delivered abdominally or receiving
prophylactic antiretroviral therapy (Kind et al., 1998).
In this paper, we analyse the temporal trends in the rate of
vertical HIV transmission in Italy by looking at a data set of
over 1000 pregnant HIV-positive women collected retrospect-
ively (1988–1990) and then prospectively (1990–1995) by a
multicentre study group (Italian Collaborative Study), which
included 13 major obstetric departments. The data on this
large number of women provides an opportunity to evaluate
the changes in the characteristics of the HIV-infected obstetric
population and the impact of obstetric management in different
calendar periods.
Materials and methods
Between January 1988 and June 1995 we studied consecutive HIV
infected women who delivered singleton live babies in 13 obstetrics
departments in Italy (Obstetrics Departments of Bari, Bologna,
Brescia, Firenze, Napoli, Padova, Pavia, Turin, Roma – Gemelli, La
Sapienza – Milan – Mangiagalli, S. Paolo, Sacco). Data were collected
on general risk factors, clinical and obstetric data during antenatal
visits and hospital stay for delivery. Information was recorded about
delivery, vaginal, elective or emergency (i.e. during labour, regardless
of the status of membranes) Caesarean section, and the neonate (birth
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weight, sex, gestational age). Data were collected on use of intravenous
drugs (heroin) and antiretroviral drugs (zidovudine) in pregnancy.
The diagnosis of maternal HIV infection was based on HIV
antibody status by ELISA and Western blot commercial kits. Mothers
were characterized by the CD41 lymphocyte count, done close to
delivery (mostly during the third trimester of pregnancy). Lymphocyte
counts have been available for all women since 1989.
If a woman delivered more than one baby in different pregnancies
during the study period, only information regarding the first singleton
livebirth was considered.
A total of 1040 women entered the study (mean age 26 years,
range 16–44). At the time of data analysis, the HIV-1 status of the
babies was known in 848 cases (81.5%). Infants were not breast fed.
They were followed up till 18 months. Children were monitored for
signs and symptoms of possible HIV-related illness. Serological tests
(ELISA and Western blot commercial kits) were repeated at 12 and
18 months. A child was classified as HIV infected if he/she fulfilled
one of the following conditions: (i) positive serological test at 18
months or more; (ii) developed clinical signs and symptoms or died
because of clinical conditions related to AIDS before 18 months.
A total of 573 cases was included in previous analyses (European
Collaborative Study, 1994).
Data analysis
We computed the vertical HIV transmission rate per calendar year
from 1988 to 1995, using the number of infected children as numerator
and the total number of children with known infection status as
denominator.
To take account in the analysis of temporal trends in vertical HIV
transmission rates, changes in clinical characteristics and mode of
delivery, rates were directly standardized according to CD41 count
(,400, ù400), gestational age at delivery (,37, ù37 weeks), and
mode of delivery (vaginal delivery or Caesarean section), taking the
population of 1988 as reference.
To analyse details of the risk of HIV vertical transmission, we
computed the odds ratios (OR) of the association between several
factors and the infant’s HIV serological status, together with their
95% approximate confidence intervals (CI), by the Mantel–Haenszel
procedure (Mantel and Haenszel, 1959). When a factor could be
classified in more than two levels, the statistical significance of the
association was assessed by the χ2 test for trend (Mantel, 1963). To
account simultaneously for the effects of several potential confounding
factors, we used unconditional multiple logistic regression, with
maximum likelihood fitting, to obtain OR and their corresponding
95% CI (Breslow and Day, 1980). Included in the regression were
terms for the factors significantly associated with the risk of mother-
to-child HIV infection in age-adjusted analysis conducted considering
the whole data set.
We also computed the proportion of HIV infected children attribut-
able to factors statistically associated with the risk of mother-to-child
infection. The attributable risk percentage (aetiological fraction,
attributable fraction), representing the proportion of infected children
in this study that would not have occurred if the effect(s) associated
with the risk factor(s) of interest was/were absent, is a useful measure
of public health and prevention relevance. The attributable risk for
any given set of risk factors can be computed using the multivariate
relative risk estimates and the distribution of these factors among
HIV infected children only.
Thus, using the multivariate relative risks, population attributable
risks were computed for each separate factor, and the factors combined,
using the method described by Bruzzi et al. (1985), which provides
a summary attributable risk (AR) for multiple factors, after allowance
for confounding. The method requires information only on the joint
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Table I. Frequency of HIV infected and uninfected children born in 13
obstetric departments in Italy, 1988–1995 calendar year. Italy 1988–1995
Calendar year Infected Non-infected
No. (% of total no.) No.
1988 16 (15.7) 86
1989 21 (17.6) 98
1990 23 (17.4) 109
1991 23 (18.8) 99
1992 17 (14.4) 101
1993 16 (13.6) 102
1994 10 (13.3) 65
1995a 6 (9.7) 56
aData from January to June.
distribution of the risk factors among infected children and on the
adjusted OR associated with each risk factor. Provided that unbiased
OR estimates are obtained and that the infected children can be
assumed to be representative of all cases in the population in terms
of exposure distribution, this method can be applied. It has to be
noted that, whenever risk factors are not mutually exclusive, their
combined attributable risk will differ from the simple sum of the
attributable risks of each factor.
Results
Table I shows the HIV mother-to-child transmission rate
according to calendar year. Rates were highest in the period
1988–1991, then tended to decrease, and in 1995 the rate was
9.7 per 100 children (a finding based on only six infected
children). This trend, however, was not statistically significant.
In order to analyse determinants of vertical HIV infection
rates in different calendar periods, we analysed the potential
risk factors for mother-to-child HIV transmission in the overall
series and in strata of the quadrennia 1988–1991 (transmission
rate of 17.5/100 children) and 1992–1995 (13.1/100 children).
The distribution of maternal characteristics according to
infection status of the children and calendar year is considered
in Table II. Considering the overall series, the risk of HIV
vertical transmission was higher in women with low CD4
count in pregnancy (OR ,400, versus ù400 1.8, 95% CI 1.1–
2.9). Similar findings emerged when the analysis was conducted
in strata of the two quadrennia.
Table III considers obstetric factors and risk of vertical HIV
transmission. The mode of delivery and gestational age at
birth were associated with the risk of vertical transmission. In
comparison with vaginal delivery, the risk of transmission was
0.3 (95% CI 0.1–0.5) and 0.6 (95% CI 0.3–1.2) respectively
for elective and emergency delivery. The estimated OR tended
to be lower in the calendar period 1992–1995, with estimated
OR of respectively 0.4 and 0.2 for elective Caesarean delivery
in the period 1988–1991 and 1992–1995 and 0.9 and 0.3 for
emergency delivery.
In comparison with women who delivered at term (ù37
gestation weeks), the OR of HIV infection of the babies for
the whole series was 2.2 (95% CI 1.3–3.6) in women who
delivered preterm; the estimated OR were 1.6 (95% CI 0.8–
3.0) and 3.4 (95% CI 1.5–7.8) respectively for the periods
1988–1991 and 1992–1995. No association emerged between
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Table II. Distribution, and corresponding odds ratios, of HIV infected and uninfected children according to selected maternal characteristics and calendar
period, Italy 1988–1995
Total 1988–1991 1992–1995
No. infected (%) OR (95% CI) No. infected (%) OR (95% CI)
Total Total
Risk group
Intravenous drug use 49 (14.8):332 a 29 (13.3):218 b
Heterosexual transmission 22 (24.7):89 – 12 (12.9):93 –
Other or unknown 12 (22.2):54 – 8 (12.9):62 –
Maternal age (years)
,30 11 66 (17.0):388 11 27 (11.3):238 11
ù30 1.2 (0.8–1.9) 16 (21.1):76 1.3 (0.7–2.4) 20 (16.4):122 1.3 (0.7–2.5)
Zidovudine use in pregnancy
No 11 80 (17.5):457 11 44 (13.5):326 11
Yes 0.7 (0.3–1.4) 3 (16.7):18 0.8 (0.2–3.2) 5 (10.6):47 0.6 (0.2–1.7)
CD41 count
ù400 11 34 (13.9):245 11 12 (10.3):116 11
,400 1.8 (1.1–2.9) 35 (24.0):146 1.9 (1.1–3.3) 16 (16.8):95 1.7 (0.7–4.2)
Antigenaemia p 24
Negative 11 55 (17.0):323 11 21 (11.9):176 11
Positive 1.7 (0.9–3.1) 13 (27.7):47 1.7 (0.8–3.5) 6 (23.1):26 1.9 (0.6–5.8)
Intravenous drug use in pregnancy
No 11 68 (16.8):404 11 38 (13.4):284 11
Yes 1.2 (0.7–1.9) 15 (21.4):70 1.4 (0.7–2.8) 10 (13.2):76 1.0 (0.5–2.4)




Table III. Distribution, and corresponding odds ratios, of HIV infected and uninfected children according to obstetric factors and calendar period, Italy 1988–
1995
Total 1988–1991 1992–1995
No. infected (%) OR (95% CI) No. infected (%) OR (95% CI)
Total Total
Mode of delivery
Vaginal 11 67 (19.2):349 11 42 (17.7):238 11
Caesarean 0.3 (0.2–0.6) 0.5 (0.3–0.9) 0.2 (0.1–0.4)
elective 0.3 (0.1–0.5) 9 (9.7):93 0.4 (0.2–0.8) 4 (4.4):92 0.2 (0.0–0.4)
emergency 0.6 (0.3–1.2) 7 (21.2):33 0.9 (0.4–2.4) 3 (7.0):43 0.3 (0.1–1.0)
Gestational age at birth (weeks)
ù37 11 66 (16.4):402 11 36 (11.7):309 11
,37 2.2 (1.3–3.6) 17 (23.6):72 1.6 (0.8–3.0) 12 (21.1):57 3.4 (1.5–7.8)
Birth weight (g)
ù3000 11 38 (15.8):241 11 28 (14.0):200 11
,3000 1.0 (0.7–1.6) 45 (19.5):231 1.3 (0.7–2.1) 20 (12.1):165 0.7 (0.3–1.5)
Interval between rupture membranes and delivery (h)*
,4 11 8 (25.8):31 11 23 (15.8):146 11
ù4 1.0 (0.5–2.1) 1 (10.0):10 0.3 (0.0–2.9) 14 (19.7):71 1.2 (0.5–2.6)
*Data not collected since late 1991.
infection status of newborn and birth weight (after taking into
account the role of gestational week at birth) or the interval
between rupture of membranes and delivery among women
who delivered vaginally.
In the analysis of temporal trends in vertical HIV transmis-
sion rates, we computed standardized rates for all the factors
found to be significantly associated with the risk of HIV
vertical transmission in both calendar periods (Table IV). The
frequency of Caesarean section increased from 26.5% in 1988–
1991 to 36.2% in 1992–1995. Consequently, most temporal
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differences disappeared after standardization for mode of
delivery, but the rate in 1995 was still lower than in 1988–
1994. No difference was observed between crude rates and
rates standardized for CD41 count, and gestational age at birth.
We computed the proportion of HIV infected children
attributable to the factors found to be significantly associated
with vertical transmission. Since interaction terms were not
significant, their coefficient were not included in the attributable
risks presented. The 16% of HIV infected children could be
attributable, during the whole study period, to pregnancy in
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Table IV. Standardizeda HIV vertical transmission rate/100 children per
calendar year, Italy, 1988–1995
Rate/100 children standardized for
Mode of CD41 count Gestational age
Year delivery at birth (rates)
1988 15.7 15.7 15.7
1989 17.3 18.8 17.7
1990 17.7 17.3 17.0
1991 19.0 19.7 18.8
1992 14.5 13.0 12.7
1993 15.1 14.8 13.7
1994 16.0 16.2 13.6
19951 10.8 11.5 10.6
1Data from January to June.
aStandardized according to the direct method using the 1988 population as
standard.
Table V. Attributable risk of vertical HIV transmission in relation to
selected determinants and their combination, 1988–1995
Risk factor Attributable risk %
CD41 count ,400 16
Vaginal delivery 54
Preterm birth
(,37 weeks gestation) 12
women with low CD41 count, the corresponding figures for
vaginal delivery and preterm birth being 54% and 12%
(Table V).
Discussion
The results of this study show that in Italy, the frequency of
vertical HIV infection tended to decline from 1988 to 1995.
This may have been due to the higher frequency of Caesarean
section in the quadrennium 1992–1995. The main determinants
of infection were preterm birth, mode of delivery and low
CD41 count, and did not change during the study period.
No association emerged between the risk of vertical HIV
transmission and maternal age, intravenous drug use in preg-
nancy, zidovudine in pregnancy, birth weight and time of
rupture of the membranes.
The potential limitations of the study should be considered.
This is an analysis of time trends and determinants of HIV
vertical transmission in women of only one country. We think
however that it is interesting to analyse in detail data from a
specific country, in consideration of the more similar epidemiol-
ogical characteristics of women considered and modalities of
assistance to pregnancy. A large proportion of cases analysed in
this paper have already been included in previous publications
(European Collaborative Study, 1994). This analysis is focused
however on some aspects (for example, the analysis of attribut-
able risks) not presented in previous published papers. Although
the study included ~1000 HIV infected mothers, it had low
statistical power to identify an increase in the risk of vertical
HIV transmission of two or more for factors with a prevalence
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lower than 30% in the study population. The proportion of
missing data was generally limited, and there is no reason to
think that infant HIV status is associated with the probability
of missing data, since data were collected at delivery.
Information was limited on the role of zidovudine in reducing
vertical HIV transmission (only 71 women reported zidovudine
use in pregnancy in 1992–1995) and should be interpreted
cautiously, since the drug was not given at random. However,
the estimated OR of vertical HIV infection related with
zidovudine use in pregnancy did not change after taking
account of potential covariates of the treatment, i.e. CD4 levels
and modalities of HIV infection in the mother. With these
limitations, however, we did not find any association between
zidovudine use in pregnancy and risk of vertical HIV-1
transmission. Similar findings emerged from a study with
similar general design conducted in the USA between 1989
and 1994 (Landesman et al., 1996). These are not consistent
with findings from a large clinical trial conducted in the USA
showing a marked reduction of HIV infection among infants
born to women treated with zidovudine (Connor et al., 1994).
Results from non-randomized studies must be considered
cautiously, and neither our data nor the American study indicate
for how long treatment was given during pregnancy and
whether women had received the drug before pregnancy and
the infants were treated after birth. Further, it is possible that
some confounding factors can explain the lack of association
between ziduvudine in pregnancy and risk of vertical HIV-1
transmission. Along this line, it should be considered that in
this series only a small proportion of women were treated with
ziduvudine in pregnancy.
There is consistent evidence that low CD41 levels are
associated with an increased risk of vertical HIV transmission.
For example, in the American Women and Infants Transmission
Study, the risk of mother-to-child HIV transmission was about
double in mothers with CD41 cells ,29% compared to
those with ù29% (Landesman et al., 1996). Other studies in
European and African populations (Ryder et al., 1989; St
Louis et al., 1993; European Collaborative Study, 1996) gave
similar results. Few data are available on how blood antigen
levels affect the risk of HIV vertical transmission.
Analysis of the Collaborative European Study (including
about 570 of the women considered in the present paper)
suggested that Caesarean section may reduce the risk of HIV-
1 vertical transmission (European Collaborative Study, 1994).
A meta-analysis including data from 11 studies and about
3200 cases indicated that the reduction associated with Caesa-
rean section amounted to ~20% (Dunn et al., 1994). However,
the Women and Infants Transmission Study conducted in the
USA (Landesman et al., 1996) and French perinatal cohorts
(Mandelbrot et al., 1996) did not confirm these data.
In this study, the estimated OR for vertical HIV transmission
was 0.3 in women who delivered by Caesarean section in
comparison with those who delivered vaginally, confirming
the protective effect. The consistency of the protection in
different calendar periods gives some strength to this associ-
ation. The higher proportion of Caesarean sections in the period
1992–1995 in comparison with 1988–1991 partly explains the
lower vertical transmission rates in recent years. In fact, the
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standardized rate of vertical transmission for mode of delivery
was similar for all periods considered.
The association between low birth weight and mother-to-
child infection has been analysed in several studies, but the
results are conflicting (Lepage et al., 1993; Nair et al., 1993;
Monfenson, 1994; Abrams et al., 1995). At least two American
and African studies have shown an increased risk for low birth
weight infants, but others did not confirm this. The association
between low birth weight and vertical HIV transmission, may
possibly be explained by the confounding effect of intravenous
drug use in pregnancy, which is associated both with low birth
weight and HIV vertical transmission or a more advanced
stage of HIV infection in the mother. We did not find any
association between birth weight and risk of mother-to-child
HIV infection. However, we did find an association between
preterm birth and risk of vertical HIV transmission. A similar
association was seen in the Women and Infants Transmission
Study and Prenatal cohorts (Landesman et al., 1996), but no
association emerged between gestational age and risk of
vertical HIV transmission in other studies (Ryder et al., 1989;
Bucceri et al., 1997).
A USA study (Landesman et al., 1996) suggested that when
the duration of ruptured membranes is 4 h or more, mother-
to-child HIV-1 transmission increases by ~5% and the risk of
vertical transmission tends to rise with the time of ruptured
membranes. In this study, we only had information on the
duration of ruptured membranes for the period 1992–1995,
but we did not find any association with risk of HIV vertical
transmission.
Finally, with regard to the proportion of HIV infected
children attributable to the various factors, ~10% of infected
children are attributable to preterm birth, a factor not prevent-
able, but ~50% of HIV infected children were preventable by
Caesarean section.
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